This is an old revision of the document!
Innovative Medicines Canada
Member Companies
The following is the list of companies displayed on the Member Companies page of IMC's website, and in their 2019 Annual Report.1) 2) The status of those that appeared in the Annual Report, but not the current webpage, is unknown.
Health Research Foundation
Canada’s Health Research Foundation (HRF) is a non-profit organization that invests in health research in Canadian academic centres, and promotes the benefits and values of research-driven health innovation in Canada. Innovative Medicines Canada members “generously contribute a million dollars annually to the HRF ensuring such research will continue to benefit Canadians for years to come.”3)
Lobbying Government
Innovative Medicines Canada lobbies Doug Ford's Government of Ontario through lobbying firm Rubicon Strategy.4) 5) The company seeks to “collaborate with government to ensure ‘Transfer of Value’ Regulations avoid unintended consequences and support a sustainable, balanced and credible approach” surrounding the “Health Sector Payment Transparency ACT”.6)
1)
Member Companies. (2021). Innovative Medicines Canada. http://innovativemedicines.ca/about/member-companies/
2)
Annual Report 2019. Innovative Medicines Canada Annual Report; Innovative Medicines Canada. Retrieved January 2, 2022, from https://www.imcannualreport.ca/download/2019AnnualReviewEN.pdf
3)
About. (2014). Health Research Foundation. https://archive.ph/NcARV
4)
Sturgess, L. (2021, December 12). COVID-19 Report #1: Rubicon Strategy. COVID-19 Reports; Substack. https://archive.ph/tSizV
5)
Ronnie. (2021, October 2). Kory Teneycke, Rubicon Strategy, And The Puppets That Are Ford, Kenney & Harper. Canuck Law. https://archive.ph/PC2Th
6)
Letersky, S. (2021, September 22). Consultant Lobbyist Registration No. CL4899-20200917025456. Office of the Integrity Commissioner; Government of Ontario. https://www.campfire.wiki/lib/exe/fetch.php?media=screencapture-lobbyist-oico-on-ca-pages-public-publicsearch-consultantlobbyistpreview-aspx-2022-01-02-12_44_20.pdf